Spectrum of Fungal Sinusitis



Nasal Polyposis Middle Turbinate Allergic Bronchopulmonary Aspergillosis Fungal Ball Allergic Fungal Sinusitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    deShazo RD, O'Brien M, Chapin K, et al. A new classification and diagnostic criteria for invasive fungal sinusitis. Arch Otolaryngol Head Neck Surg 1997;123:1181–1188.PubMedCrossRefGoogle Scholar
  2. 2.
    deShazo RD, Chapin K, Swain RE. Fungal sinusitis. N Engl J Med 1997;337:254–259.PubMedCrossRefGoogle Scholar
  3. 3.
    Ferreiro JA, Carlson BA, Cody DT III. Paranasal sinus fungus balls. Head Neck 1997;19: 481–486.PubMedCrossRefGoogle Scholar
  4. 4.
    Safirstein BH. Allergic bronchopulmonary aspergillosis with obstruction of the upper respiratory tract. Chest 1976;70:788–790.PubMedCrossRefGoogle Scholar
  5. 5.
    Millar J, Johnston A, Lamb B. Allergic aspergillosis of the maxillary sinuses [abstract]. Thorax 1981;36:710.Google Scholar
  6. 6.
    Bent JP III, Kuhn FA. Diagnosis of allergic fungal sinusitis. Otolaryngol Head Neck Surg 1994;111:580–588.PubMedCrossRefGoogle Scholar
  7. 7.
    Ferguson BJ. Eosinophilic mucin rhinosinusitis: a distinct clinicopathological entity. Laryngoscope 2000;110:799–813.PubMedCrossRefGoogle Scholar
  8. 8.
    Carney AS, Tan LW, Adams D, et al. Th2 immunological inflammation in allergic fungal sinusitis, nonallergic eosinophilic fungal sinusitis, and chronic rhinosinusitis. Am J Rhinol 2006;20:145–149.PubMedGoogle Scholar
  9. 9.
    Pant H, Kette FE, Smith WB, et al. Eosinophilic mucus chronic rhinosinusitis: clinical subgroups or a homogeneous pathogenic entity? Laryngoscope 2006;116:1241–1247.PubMedCrossRefGoogle Scholar
  10. 10.
    Eliashar R, Levi-Schaffer F. The role of the eosinophil in nasal diseases. Curr Opin Otolaryngol Head Neck Surg 2005;13:171–175.PubMedCrossRefGoogle Scholar
  11. 11.
    Collins M, Nair S, Smith W, et al. Role of local immunoglobulin E production in the pathophysiology of noninvasive fungal sinusitis. Laryngoscope 2004;114:1242–1246.PubMedCrossRefGoogle Scholar
  12. 12.
    Ponikau JU, Sherris DA, Kern EB, et al. The diagnosis and incidence of allergic fungal sinusitis. Mayo Clin Proc 1999;74:877–884.Google Scholar
  13. 13.
    Kuhn FA, Swain R Jr. Allergic fungal sinusitis: diagnosis and treatment. Curr Opin Otolaryngol Head Neck Surg 2003;11:1–5.PubMedCrossRefGoogle Scholar
  14. 14.
    Marple BF, Mabry RL. Comprehensive management of allergic fungal sinusitis. Am J Rhinol 1998;12:263–268.PubMedCrossRefGoogle Scholar
  15. 15.
    Waxman JE, Spector JG, Sale SR, et al. Allergic Aspergillus sinusitis: concepts in diagnosis and treatment of a new clinical entity. Laryngoscope 1987;97:261–266.PubMedCrossRefGoogle Scholar
  16. 16.
    Schubert MS. Allergic fungal sinusitis: pathogenesis and management strategies. Drugs 2004;64:363–374.PubMedCrossRefGoogle Scholar
  17. 17.
    Kupferberg SB, Bent JP III, Kuhn FA. Prognosis for allergic fungal sinusitis. Otolaryngol Head Neck Surg 1997;117:35–41.PubMedCrossRefGoogle Scholar
  18. 18.
    Kinsella JB, Bradfield JJ, Gourley WK, et al. Allergic fungal sinusitis. Clin Otolaryngol Allied Sci 1996;21:389–392.PubMedCrossRefGoogle Scholar
  19. 19.
    Schubert MS. Medical treatment of allergic fungal sinusitis. Ann Allergy Asthma Immunol 2000;85:90–97; quiz 97–101.PubMedCrossRefGoogle Scholar
  20. 20.
    Mabry RL, Mabry CS. Allergic fungal sinusitis: the role of immunotherapy. Otolaryngol Clin N Am 2000;33:433–440.CrossRefGoogle Scholar
  21. 21.
    Bassichis BA, Marple BF, Mabry RL, et al. Use of immunotherapy in previously treated patients with allergic fungal sinusitis. Otolaryngol Head Neck Surg 2001;125:487–490.PubMedGoogle Scholar
  22. 22.
    Folker RJ, Marple BF, Mabry RL, et al. Treatment of allergic fungal sinusitis: a comparison trial of postoperative immunotherapy with specific fungal antigens. Laryngoscope 1998;108:1623–1627.PubMedCrossRefGoogle Scholar
  23. 23.
    Mabry RL, Manning SC, Mabry CS. Immunotherapy in the treatment of allergic fungal sinusitis. Otolaryngol Head Neck Surg 1997;116:31–35.PubMedCrossRefGoogle Scholar
  24. 24.
    Denning DW, Van Wye JE, Lewiston NJ, et al. Adjunctive therapy of allergic bronchopulmonary aspergillosis with itraconazole. Chest 1991;100:813–819.PubMedCrossRefGoogle Scholar
  25. 25.
    Bent JP III, Kuhn FA. Antifungal activity against allergic fungal sinusitis organisms. Laryngoscope 1996;106:1331–1334.PubMedCrossRefGoogle Scholar
  26. 26.
    Marple BF. Allergic fungal rhinosinusitis: current theories and management strategies. Laryngoscope 2001;111:1006–1019.PubMedCrossRefGoogle Scholar
  27. 27.
    Rains BM 3rd, Mineck CW. Treatment of allergic fungal sinusitis with high-dose itraconazole. Am J Rhinol 2003;17:1–8.PubMedGoogle Scholar
  28. 28.
    Ferguson BJ. What role do systemic corticosteroids, immunotherapy, and antifungal drugs play in the therapy of allergic fungal rhinosinusitis? Arch Otolaryngol Head Neck Surg 1998;124:1174–1178.PubMedGoogle Scholar
  29. 29.
    Greenberg RN, Scott LJ, Vaughn HH, et al. Zygomycosis (mucormycosis): emerging clinical importance and new treatments. Curr Opin Infect Dis 2004;17:517–525.PubMedCrossRefGoogle Scholar
  30. 30.
    Greenberg RN, Mullane K, van Burik JA, et al. Posaconazole as salvage therapy for zygomycosis. Antimicrob Agents Chemother 2006;50:126–133.PubMedCrossRefGoogle Scholar
  31. 31.
    Prabhu RM, Patel R. Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment. Clin Microbiol Infect 2004;10(suppl 1):31–47.PubMedCrossRefGoogle Scholar
  32. 32.
    Hejny C, Kerrison JB, Newman NJ, et al. Rhino-orbital mucormycosis in a patient with acquired immunodeficiency syndrome (AIDS) and neutropenia. Am J Ophthalmol 2001;132:111–112.PubMedCrossRefGoogle Scholar
  33. 33.
    Gillespie MB, O'Malley BW Jr, Francis HW. An approach to fulminant invasive fungal rhinosinusitis in the immunocompromised host. Arch Otolaryngol Head Neck Surg 1998;124:520–526.PubMedGoogle Scholar
  34. 34.
    Gillespie MB, O'Malley BW. An algorithmic approach to the diagnosis and management of invasive fungal rhinosinusitis in the immunocompromised patient. Otolaryngol Clin N Am 2000;33:323–334.CrossRefGoogle Scholar
  35. 35.
    Gillespie MB, Huchton DM, O'Malley BW. Role of middle turbinate biopsy in the diagnosis of fulminant invasive fungal rhinosinusitis. Laryngoscope 2000;110:1832–1836.PubMedCrossRefGoogle Scholar
  36. 36.
    Tarrand JJ, Lichterfeld M, Warraich I, et al. Diagnosis of invasive septate mold infections. A correlation of microbiological culture and histologic or cytologic examination. Am J Clin Pathol 2003;119:854–858.PubMedCrossRefGoogle Scholar
  37. 37.
    DelGaudio JM, Swain RE Jr, Kingdom TT, et al. Computed tomographic findings in patients with invasive fungal sinusitis. Arch Otolaryngol Head Neck Surg 2003;129:236–240.PubMedCrossRefGoogle Scholar
  38. 38.
    Press GA, Weindling SM, Hesselink JR, et al. Rhinocerebral mucormycosis: MR manifestations. J Comput Assist Tomogr 1988;12:744–749.PubMedCrossRefGoogle Scholar
  39. 39.
    Blitzer A, Lawson W, Meyers BR, et al. Patient survival factors in paranasal sinus mucormycosis. Laryngoscope 1980;90:635–648.PubMedCrossRefGoogle Scholar
  40. 40.
    Yohai RA, Bullock JD, Aziz AA, et al. Survival factors in rhino-orbital-cerebral mucormycosis. Surv Ophthalmol 1994;39:3–22.PubMedCrossRefGoogle Scholar
  41. 41.
    Kohn R, Hepler R. Management of limited rhino-orbital mucormycosis without exenteration. Ophthalmology 1985;92:1440–1444.PubMedGoogle Scholar
  42. 42.
    Hargrove RN, Wesley RE, Klippenstein KA, et al. Indications for orbital exenteration in mucormycosis. Ophthalmol Plast Reconstr Surg 2006;22:286–291.CrossRefGoogle Scholar
  43. 43.
    Herbrecht R, Letscher-Bru V, Bowden RA, et al. Treatment of 21 cases of invasive mucormycosis with amphotericin B colloidal dispersion. Eur J Clin Microbiol Infect Dis 2001;20: 460–466.PubMedCrossRefGoogle Scholar
  44. 44.
    Herbrecht R. Posaconazole: a potent, extended-spectrum triazole anti-fungal for the treatment of serious fungal infections. Int J Clin Pract 2004;58:612–624.PubMedCrossRefGoogle Scholar
  45. 45.
    Rutar T, Cockerham KP. Periorbital zygomycosis (mucormycosis) treated with posaconazole. Am J Ophthalmol 2006;142:187–188.PubMedCrossRefGoogle Scholar
  46. 46.
    Sun QN, Najvar LK, Bocanegra R, et al. In vivo activity of posaconazole against Mucor spp. in an immunosuppressed-mouse model. Antimicrob Agents Chemother 2002;46:2310–2312.Google Scholar
  47. 47.
    Busaba NY, Colden DG, Faquin WC, et al. Chronic invasive fungal sinusitis: a report of two atypical cases. Ear Nose Throat J 2002;81:462–466.PubMedGoogle Scholar
  48. 48.
    Washburn RG, Kennedy DW, Begley MG, et al. Chronic fungal sinusitis in apparently normal hosts. Medicine (Baltim) 1988;67:231–247.Google Scholar
  49. 49.
    Boucher HW, Groll AH, Chiou CC, et al. Newer systemic antifungal agents: pharmacokinetics, safety and efficacy. Drugs 2004;64:1997–2020.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  1. 1.Department of Otorhinolaryngology – Head and Neck SurgeryUniversity of Pennsylvania Health SystemPhiladelphiaUSA

Personalised recommendations